- Home
- Publications
- Publication Search
- Publication Details
Title
Trial Watch
Authors
Keywords
-
Journal
OncoImmunology
Volume 2, Issue 12, Pages e26621
Publisher
Informa UK Limited
Online
2014-01-26
DOI
10.4161/onci.26621
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting dendritic cells--why bother?
- (2013) M. Kreutz et al. BLOOD
- Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma
- (2013) K Yoshimura et al. BRITISH JOURNAL OF CANCER
- Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund’s adjuvant, with or without peptide
- (2013) Elise P. Salerno et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer
- (2013) Daniela Fenoglio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment
- (2013) H. Reuveni et al. CANCER RESEARCH
- Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients
- (2013) Ryuji Takahashi et al. CANCER SCIENCE
- Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer
- (2013) Hajime Ishikawa et al. Gastric Cancer
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer
- (2013) Guru Sonpavde et al. INVESTIGATIONAL NEW DRUGS
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy
- (2013) Fernando Ulloa-Montoya et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting of Antigens to B Lymphocytes via CD19 as a Means for Tumor Vaccine Development
- (2013) Y. Ma et al. JOURNAL OF IMMUNOLOGY
- Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
- (2013) Hiroyuki Suzuki et al. Journal of Translational Medicine
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- Synthesized Multiple Antigenic Polypeptide Vaccine Based on B-Cell Epitopes of Human Heparanase Could Elicit a Potent Antimetastatic Effect on Human Hepatocellular Carcinoma In Vivo
- (2013) Jun Zhang et al. PLoS One
- Breast Cancer Antiestrogen Resistance 3 (BCAR3) Promotes Cell Motility by Regulating Actin Cytoskeletal and Adhesion Remodeling in Invasive Breast Cancer Cells
- (2013) Ashley L. Wilson et al. PLoS One
- Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors
- (2013) F. Sandoval et al. Science Translational Medicine
- Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination
- (2013) Yu Sawada et al. Human Vaccines & Immunotherapeutics
- Immunotherapy of HPV-associated head and neck cancer
- (2013) Mevyn Nizard et al. OncoImmunology
- Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
- (2013) Magalie Dosset et al. OncoImmunology
- Novel multifunctional antibody approved for the treatment of breast cancer
- (2013) Domenico Mavilio et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands
- (2013) Valerie Chew et al. OncoImmunology
- The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
- (2013) Aaron S. Mansfield et al. OncoImmunology
- New immunotherapeutic paradigms for castration-resistant prostate cancer
- (2013) Lorenzo Galluzzi OncoImmunology
- Victories and deceptions in tumor immunology
- (2013) Guido Kroemer et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Interferon α may be back on track to treat acute myeloid leukemia
- (2013) Evelien L.J.M. Smits et al. OncoImmunology
- Trial watch
- (2013) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+head and neck cancer cells
- (2013) Chwee Ming Lim et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Laurie Menger et al. OncoImmunology
- A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
- (2012) Tim F Greten et al. BMC CANCER
- TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome
- (2012) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
- (2012) Jürgen C. Becker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
- (2012) Mads Hald Andersen CANCER IMMUNOLOGY IMMUNOTHERAPY
- SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group
- (2012) Satoshi Kawaguchi et al. CANCER SCIENCE
- Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients
- (2012) Hidekazu Kameshima et al. CANCER SCIENCE
- Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors
- (2012) Isamu Okamoto et al. CANCER SCIENCE
- Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor
- (2012) Hidetoshi Hayashi et al. CANCER SCIENCE
- Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I-Modified Peptides
- (2012) P. Filipazzi et al. CLINICAL CANCER RESEARCH
- Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
- (2012) M. Dosset et al. CLINICAL CANCER RESEARCH
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
- (2012) P. Sabbatini et al. CLINICAL CANCER RESEARCH
- Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
- (2012) C. A. Crane et al. CLINICAL CANCER RESEARCH
- Vaccination using peptides spanning the SYT–SSX tumor-specific translocation
- (2012) Jordan E Bloom et al. Expert Review of Vaccines
- Cancer vaccines: should we be targeting patients with less aggressive disease?
- (2012) Diane F Hale et al. Expert Review of Vaccines
- Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity
- (2012) Kirstine Lavrsen et al. GLYCOCONJUGATE JOURNAL
- Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide
- (2012) Shingo Eikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase I/II clinical trial
- (2012) Eliane C.M. Zeestraten et al. INTERNATIONAL JOURNAL OF CANCER
- WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial
- (2012) Takashi Miyatake et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
- (2012) Erika Hamilton et al. Journal of Translational Medicine
- ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner
- (2012) Huai-Xiang Hao et al. NATURE
- Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors
- (2012) Bon-Kyoung Koo et al. NATURE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia
- (2012) E Lainey et al. ONCOGENE
- Louis Pasteur, the Father of Immunology?
- (2012) Kendall A. Smith Frontiers in Immunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Combining targeted therapy with immunotherapy (interferon-α)
- (2012) Lei L. Chen et al. OncoImmunology
- Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment
- (2012) Adriana J. Michielsen et al. OncoImmunology
- Can the exome and the immunome converge on the design of efficient cancer vaccines?
- (2012) Guido Kroemer et al. OncoImmunology
- NY-ESO-1 expression in sarcomas
- (2012) Jin-Ping Lai et al. OncoImmunology
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
- (2012) Else-Marit Inderberg-Suso et al. OncoImmunology
- Understanding key assay parameters that affect measurements of trastuzumab-mediated ADCC against Her2 positive breast cancer cells
- (2012) Timothy Kute et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study
- (2011) A. Kotsakis et al. ANNALS OF ONCOLOGY
- Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination
- (2011) C. Pospori et al. BLOOD
- Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001
- (2011) Eleni-Kyriaki Vetsika et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
- (2011) Robert E. Hunger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
- (2011) Else M. Inderberg Suso et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting p53 to mitochondria for cancer therapy
- (2011) Lorenzo Galluzzi et al. CELL CYCLE
- Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia
- (2011) Sylvain Thépot et al. CELL CYCLE
- The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation
- (2011) Holger Hackstein et al. CELLULAR IMMUNOLOGY
- Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
- (2011) Alja Oblak et al. Clinical & Developmental Immunology
- Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
- (2011) J. A. Kyte et al. CLINICAL CANCER RESEARCH
- Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
- (2011) P. F. Brunsvig et al. CLINICAL CANCER RESEARCH
- Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies
- (2011) R. Vermeij et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
- (2011) Stephen J. Schuster et al. JOURNAL OF CLINICAL ONCOLOGY
- Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphoma
- (2011) Christoph Schlapbach et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Edward Jenner and the Small Pox Vaccine
- (2011) Kendall A. Smith Frontiers in Immunology
- Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma
- (2010) A. P. Rapoport et al. BLOOD
- Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation
- (2010) K. Birkholz et al. BLOOD
- LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling
- (2010) R Matsuda et al. BRITISH JOURNAL OF CANCER
- Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
- (2010) Redas Trepiakas et al. CYTOTHERAPY
- Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos
- (2010) Ilio Vitale et al. EMBO JOURNAL
- Expression of aberrantly glycosylated Mucin-1 in ovarian cancer
- (2010) Catharina H M J Van Elssen et al. HISTOPATHOLOGY
- MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies
- (2010) Elke Schultz-Thater et al. INTERNATIONAL JOURNAL OF CANCER
- Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity
- (2010) T. Tsuji et al. JOURNAL OF IMMUNOLOGY
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lack of specific -retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation
- (2009) W. R. Burns et al. BLOOD
- Cancer vaccination with telomerase peptide GV1001
- (2009) Jon Amund Kyte EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Topical resiquimod: a promising adjuvant for vaccine development?
- (2009) Manoli Igartua et al. Expert Review of Vaccines
- New perspectives in cancer immunotherapy and immunomonitoring
- (2009) Viktor Umansky et al. Future Oncology
- Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs
- (2009) Mark M Aloysius et al. Journal of Translational Medicine
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Immune Responses in Patients with Metastatic Renal Cell Carcinoma Treated with Dendritic Cells Pulsed with Tumor Lysate
- (2009) A. Soleimani et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Carcinomas of an unknown primary site: a curable disease?
- (2008) A. Levy et al. ANNALS OF ONCOLOGY
- IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder
- (2008) L. Sitnikova et al. CLINICAL CANCER RESEARCH
- Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity
- (2008) G. G. Kenter et al. CLINICAL CANCER RESEARCH
- Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding
- (2008) Sjoerd H van der Burg Expert Review of Vaccines
- Therapeutic Dendritic Cell Vaccination of Patients With Metastatic Renal Cell Carcinoma
- (2008) Annika Berntsen et al. JOURNAL OF IMMUNOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now